• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Plasma and tissue concentrations of cefamandole during cardiac surgery].

作者信息

Clavey M, Weber M, Hubert T, Delanoë B, Poussot C, Hottier E, Villemot J P

机构信息

Département d'Anesthésie-Réanimation, CHR de Brabois, Vandoeuvre-lès-Nancy.

出版信息

Ann Fr Anesth Reanim. 1989;8(4):316-20. doi: 10.1016/S0750-7658(89)80072-3.

DOI:10.1016/S0750-7658(89)80072-3
PMID:2817542
Abstract

This study aimed to determine plasma (CPC) and tissue concentrations of cefamandole during cardiac surgery, so as to compare them with the minimal inhibitory concentration (MIC) for staphylococci (0.25 - 1 microgram.ml-1 for S. aureus; 2 micrograms.ml-1 for S. epidermidis). Cefamandole was given prophylactically to 8 consecutive patients as a single intravenous dose of 60 mg.kg-1. Tissue concentrations were measured in presternal subcutaneous loose tissue and sternal marrow. Average CPC was 233.75 +/- 58 micrograms.ml-1, 15 min after drug administration, 187 +/- 6.4 micrograms.ml-1 at the time of sternotomy, 57.9 +/- 36.5 micrograms.ml-1 10 min after the start of bypass and 36.4 +/- 18.4 micrograms.ml-1 at its end, and 15.5 +/- 5.9 micrograms.ml-1 at the end of the procedure. Sternal subcutaneous tissue and marrow concentrations were respectively 24.4 +/- 13.3 micrograms.g-1 and 31 +/- 5.6 micrograms.g-1 at the time of sternotomy, and 9.4 +/- 5.5 micrograms.g-1 and 9.2 +/- 3.5 micrograms.g-1 at the end of the procedure. Giving a high dose of cefamandole preoperatively appeared to have an effective prophylactic antibiotic action, as the plasma and tissue concentrations were always higher than the MIC for staphylococci.

摘要

相似文献

1
[Plasma and tissue concentrations of cefamandole during cardiac surgery].
Ann Fr Anesth Reanim. 1989;8(4):316-20. doi: 10.1016/S0750-7658(89)80072-3.
2
[The effect of different autotransfusion procedures on the antibiotic picture. A study on cephalosporin cefamandole].[不同自体输血程序对抗生素情况的影响。头孢孟多的研究]
Anaesthesist. 1993 Aug;42(8):509-15.
3
Concentration of cefamandole in plasma and tissues of patients undergoing cardiac surgery: the influence of different cefamandole dosage.
J Cardiothorac Vasc Anesth. 1997 Aug;11(5):565-70. doi: 10.1016/s1053-0770(97)90005-7.
4
[Antibiotic prophylaxis using a combination of pefloxacin and fosfomycin in heart surgery with CEC (extracorporeal circulation) in patients allergic to beta-lactams].
Cah Anesthesiol. 1989 Mar-Apr;37(2):77-87.
5
Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
Obstet Gynecol. 1983 Jan;61(1):42-7.
6
Comparative study between two prophylactic antibiotic regimens of cefamandole during coronary artery bypass surgery.冠状动脉搭桥手术中两种头孢孟多预防性抗生素方案的比较研究
Ann Thorac Surg. 1988 Jan;45(1):24-7. doi: 10.1016/s0003-4975(10)62389-2.
7
Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.心脏手术患者血清和心耳中夫西地酸、氯唑西林和头孢孟多的浓度。
Antimicrob Agents Chemother. 1985 Jun;27(6):928-32. doi: 10.1128/AAC.27.6.928.
8
[A pharmacokinetic study of diffusion in adenomatous prostatic tissue of an intravenous bolus of cefamandole].
Ann Urol (Paris). 1990;24(2):141-5.
9
Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial.头孢唑林、头孢孟多和万古霉素用于心脏和血管手术预防性抗菌治疗的比较研究。一项双盲随机试验。
J Thorac Cardiovasc Surg. 1992 Nov;104(5):1423-34.
10
[Perioperative preventive antibiotic treatment with fosfomycin in heart surgery: serum kinetics in extracorporeal circulation and determination of concentration in heart valve tissue].
Z Kardiol. 1990 Sep;79(9):615-20.